Itau Unibanco Holding S.A.’s Beam Therapeutics BEAM Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-236	Closed	-$6.42K	–	150
2023 Q4	$6.42K	Sell	236 -717	-75%	-$17.8K	﹤0.01%	333
2023 Q3	$22.9K	Buy	953 +220	+30%	+$5.9K	﹤0.01%	358
2023 Q2	$23.4K	Buy	733 +440	+150%	+$14.3K	﹤0.01%	391
2023 Q1	$8.97K	Sell	293 -64	-18%	-$2.53K	﹤0.01%	456
2022 Q4	$13.8K	Sell	357 -444	-55%	-$19.9K	﹤0.01%	434
2022 Q3	$38K	Sell	801 -370	-32%	-$21.1K	﹤0.01%	404
2022 Q2	$45K	Buy	1,171 +45	+4%	+$1.79K	﹤0.01%	333
2022 Q1	$65K	Buy	1,126 +16	+1%	+$1.05K	﹤0.01%	296
2021 Q4	$91K	Buy	+1,110	New	+$95K	﹤0.01%	225

Other funds holding BEAM

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Itau Unibanco Holding S.A.'s BEAM Position: Q1 2024 in Review

Itau Unibanco Holding S.A. sold out of Beam Therapeutics (BEAM) in Q1 2024, closing a stake of 236 shares — an estimated $6.42K sold.

Itau Unibanco Holding S.A. first reported a position in BEAM in Q4 2021 and held it in 9 quarters. The position peaked at $91K in Q4 2021. 221 funds tracked by Wall St. Rank hold BEAM as of Q1 2024.

Itau Unibanco Holding S.A. reported no remaining Beam Therapeutics position as of Q1 2024 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 236 Beam Therapeutics shares in Q1 2024, an estimated $6.42K.
Itau Unibanco Holding S.A. first reported a position in Beam Therapeutics in Q4 2021 and held it in 9 quarters.
Itau Unibanco Holding S.A.'s Beam Therapeutics position peaked at $91K in Q4 2021.
221 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2024, filed 14 May 2024.